Group One Trading
SLDB icon

Group One Trading’s Solid Biosciences SLDB Stock Holding History

Group One Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,400
Closed -$31.7K – 8417
2026
Q1 		$31.7K Buy
4,400
+4,300
+4,300% +$27.6K ﹤0.01% 5618
2025
Q4 		$564 Sell
100
-1,000
-91% -$5.42K ﹤0.01% 7795
2025
Q3 		$6.79K Sell
1,100
-1,400
-56% -$8.19K ﹤0.01% 7397
2025
Q2 		$12.2K Sell
2,500
-17,700
-88% -$62.6K ﹤0.01% 6594
2025
Q1 		$74.7K Buy
20,200
+18,500
+1,088% +$79.2K ﹤0.01% 4838
2024
Q4 		$6.8K Buy
+1,700
New +$9.34K ﹤0.01% 6287
2023
Q2 		– Sell
-1,000
Closed -$4.74K – 8164
2023
Q1 		$4.74K Hold
1,000
– – ﹤0.01% 6300
2022
Q4 		$5.38K Buy
1,000
+733
+275% +$4.8K ﹤0.01% 6314
2022
Q3 		$2K Buy
+267
New +$2.69K ﹤0.01% 7203
2022
Q1 		– Sell
-87
Closed -$2K – 8646
2021
Q4 		$2K Sell
87
-653
-88% -$20K ﹤0.01% 7905
2021
Q3 		$27K Buy
740
+407
+122% +$17.3K ﹤0.01% 6997
2021
Q2 		$18K Sell
333
-747
-69% -$49.4K ﹤0.01% 7259
2021
Q1 		$90K Buy
1,080
+240
+29% +$26.6K ﹤0.01% 5751
2020
Q4 		$96K Buy
840
+733
+685% +$46.4K ﹤0.01% 4593
2020
Q3 		$3K Sell
107
-733
-87% -$28.1K ﹤0.01% 5770
2020
Q2 		$37K Sell
840
-5,200
-86% -$216K ﹤0.01% 4539
2020
Q1 		$217K Sell
6,040
-10,593
-64% -$524K ﹤0.01% 2684
2019
Q4 		$1.11M Buy
16,633
+4,166
+33% +$460K 0.01% 1788
2019
Q3 		$1.93M Buy
12,467
+8,920
+251% +$1.01M 0.02% 1243
2019
Q2 		$306K Sell
3,547
-586
-14% -$63.9K ﹤0.01% 2547
2019
Q1 		$570K Buy
4,133
+4,006
+3,154% +$1M 0.01% 1842
2018
Q4 		$51K Buy
+127
New +$59.7K ﹤0.01% 3552

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's SLDB Position: Q2 2026 in Review

Group One Trading opened a new position in Solid Biosciences (SLDB) in Q2 2026: 4,230 shares worth $42.3K. The stake represents ﹤0.01% of the portfolio and ranks #5502 among its holdings. This is a return to the name: Group One Trading previously reported a position in SLDB as recently as Q4 2025.

Group One Trading first reported a position in SLDB in Q3 2018 and has held it in 23 quarters since. The position peaked at $479K in Q2 2019. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Group One Trading held 4,230 shares of Solid Biosciences worth $42.3K as of Q2 2026.
  • Solid Biosciences was a new Group One Trading position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5502 holding.
  • Group One Trading first reported a position in Solid Biosciences in Q3 2018 and has held it in 23 quarters since.
  • Group One Trading's Solid Biosciences position peaked at $479K in Q2 2019.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.